サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413824

病理学におけるAI市場：コンポーネント、ニューラルネットワーク、アプリケーション、エンドユーザー別-2024-2030年の世界予測

AI in Pathology Market by Component (Hardware, Software), Neural Network (Convolutional neural networks (CNNs), Generative adversarial networks (GANs), Recurrent neural networks (RNNs)), Application, End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 183 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
病理学におけるAI市場：コンポーネント、ニューラルネットワーク、アプリケーション、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

病理学におけるAI市場規模は2023年に2,901万米ドルと推定され、2024年には3,336万米ドルに達し、CAGR 15.33%で2030年には7,875万米ドルに達すると予測されています。

病理学におけるAIの世界市場

主な市場の統計
基準年[2023］ 2,901万米ドル
予測年[2024］ 3,336万米ドル
予測年 [2030] 7,875万米ドル
CAGR（%） 15.33%
病理学におけるAI Market-IMG1

病理学における人工知能（AI）は、高度な計算技術、機械学習アルゴリズム、画像解析ツールを統合し、診断プロセスの様々な側面を自動化することで、病理診断のスピード、精度、効率を向上させる。正確で迅速な診断に対する新興国市場の開拓、タイムリーな診断を必要とするがんなどの慢性疾患の流行の高まり、デジタル病理学インフラの継続的な開発が市場の成長に強く寄与しています。加えて、研究開発活動への継続的な投資や、ヘルスケアのデジタル化を促進することを目的とした政府の支援的なイニシアチブもあります。さらに、病理学におけるAIベースのソリューションの開発と統合は、多くのヘルスケア組織にとって高額な費用となる可能性があります。また、患者データの共有にクラウドベースのソリューションを使用すると、データ漏洩や機密情報への不正アクセスに対する懸念が生じる。これとは別に、機械学習技術と人工知能機能の急速な進歩は、市場成長の潜在的機会を生み出しています。さらに、ブロックチェーンなどの新たな技術を活用することで、患者データの安全な保存と転送を確保することができます。

地域別の洞察

南北アメリカでは、デジタル診断を推進するためにAI主導の病理学ソリューションに多額の投資が行われています。食品医薬品局もAIベースの医療機器の認可を開始し、こうした技術が受け入れられつつあることを示しています。欧州委員会のプログラムは、医療・介護のデジタル変革に焦点を当てたプロジェクトに多額の資金を提供しています。EU地域におけるヘルスケア・インフラの改善は、AIベースの病理学ソリューションにとってまたとない機会をもたらします。APAC地域では、大手企業がデジタル診断に多額の投資を行っています。政府の取り組みもこの分野の研究開発を支援し、多数の特許や研究発表につながっています。また、APAC地域の新興経済諸国におけるヘルスケアインフラの整備は、デジタルヘルスケアソリューションの採用を後押ししています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、病理学におけるAI市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、病理学におけるAI市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-病理学におけるAI市場の市場規模および予測は？

2-病理学におけるAI市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-病理学におけるAI市場における技術動向と規制の枠組みは？

4-病理学におけるAI市場における主要ベンダーの市場シェアは？

5-病理学におけるAI市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で病理学のデジタル化が進む
      • 慢性疾患の蔓延に伴いテレパソロジーの必要性が高まる
    • 抑制要因
      • 病理学におけるAIに関連する高コスト
    • 機会
      • 病理学におけるAIの技術の進歩
      • 個別化およびカスタマイズされた医療に対する需要の高まり
    • 課題
      • データプライバシーに関する懸念
  • 市場セグメンテーション分析
    • コンポーネント：シームレスなワークフローと効率的なデータ管理を実現する病理分野の広範なソフトウェアアプリケーション
    • ニューラルネットワーク：診断の精度と効率により、敵対的生成ネットワークの採用が増加
    • 応用例：病理学におけるAIを疾患診断に広く活用し、疾患の早期発見を促進
    • エンドユーザー：潜在的な治療法を発見するための製薬会社およびバイオテクノロジー企業における病理学 AIの拡張
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 病理学におけるAI市場：コンポーネント別

  • ハードウェア
  • ソフトウェア

第7章 病理学におけるAI市場ニューラルネットワーク別

  • 畳み込みニューラルネットワーク（CNN）
  • 敵対的生成ネットワーク（GAN）
  • リカレントニューラルネットワーク（RNN）

第8章 病理学におけるAI市場：用途別

  • 臨床ワークフロー
  • 病気の診断と予後
  • 創薬
  • トレーニングと教育

第9章 病理学におけるAI市場：エンドユーザー別

  • 学術調査機関
  • 病院
  • 製薬およびバイオテクノロジー企業

第10章 南北アメリカの病理学におけるAI市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の病理学におけるAI市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの病理学におけるAI市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • aetherAI
    • Aiforia Technologies Oyj
    • Akoya Biosciences, Inc.
    • Deep Bio, Inc.
    • Evident Corporation
    • F. Hoffmann-La Roche Ltd.
    • Ibex Medical Analytics Ltd.
    • Indica Labs, Inc.
    • Inspirata, Inc.
    • LUMEA, Inc.
    • MindPeak GmbH
    • Nucleai Inc.
    • OptraSCAN Inc.
    • Paige.AI, Inc.
    • PathAI, Inc.
    • Proscia Inc.
    • Techcyte, Inc.
    • Tempus Labs, Inc.
    • Tribun Health
    • Visikol, Inc. by CELLINK
    • Visiopharm A/S
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. AI IN PATHOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. AI IN PATHOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. AI IN PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AI IN PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. AI IN PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AI IN PATHOLOGY MARKET DYNAMICS
  • FIGURE 7. AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2023 VS 2030 (%)
  • FIGURE 10. AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. AI IN PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. AI IN PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. AI IN PATHOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. AI IN PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 6. AI IN PATHOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AI IN PATHOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 9. AI IN PATHOLOGY MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS (CNNS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AI IN PATHOLOGY MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORKS (GANS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AI IN PATHOLOGY MARKET SIZE, BY RECURRENT NEURAL NETWORKS (RNNS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. AI IN PATHOLOGY MARKET SIZE, BY CLINICAL WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AI IN PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS & PROGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AI IN PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AI IN PATHOLOGY MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. AI IN PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AI IN PATHOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AI IN PATHOLOGY MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. AI IN PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 190. AI IN PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. AI IN PATHOLOGY MARKET LICENSE & PRICING
目次
Product Code: MRR-1730A405FA4C

[183 Pages Report] The AI in Pathology Market size was estimated at USD 29.01 million in 2023 and expected to reach USD 33.36 million in 2024, at a CAGR 15.33% to reach USD 78.75 million by 2030.

Global AI in Pathology Market

KEY MARKET STATISTICS
Base Year [2023] USD 29.01 million
Estimated Year [2024] USD 33.36 million
Forecast Year [2030] USD 78.75 million
CAGR (%) 15.33%
AI in Pathology Market - IMG1

Artificial intelligence (AI) in pathology integrates advanced computational techniques, machine learning algorithms, and image analysis tools to improve pathological diagnoses' speed, accuracy, and efficiency by automating various aspects of the diagnostic process. Increasing demand for accurate and quick diagnostics, the rising chronic diseases prevalence such as cancer that require timely diagnosis, and continuous developments in digital pathology infrastructure strongly contribute to the growth of the market. In addition, ongoing investments in research and development activities and supportive government initiatives aimed at promoting healthcare digitization. Furthermore, the development and integration of AI-based solutions in pathology can be an expensive affair for many healthcare organizations. Also, the usage of cloud-based solutions for sharing patient data raises concerns about data breaches and unauthorized access to sensitive information. Apart from this, rapid advancements in machine learning techniques & artificial intelligence capabilities create a potential opportunity for market growth. Additionally, emerging technologies such as blockchain can be leveraged to ensure secure storage and transfer of patient data.

Regional Insights

In the Americas, significant investments have been made in AI-driven pathology solutions to advance digital diagnostics. The Food and Drug Administration has also started approving AI-based medical devices, demonstrating an increasing acceptance of such technologies. The European Commission's program has provided significant funding for projects focusing on digital transformation in health and care. Improved healthcare infrastructure in the EU region presents a unique opportunity for AI-based pathology solutions. In the APAC region, major players have made significant investments in digital diagnostics. Government initiatives have also supported R&D in this sector, leading to numerous patents and research publications. Also, the development of healthcare infrastructure in the developing economies of the APAC region endorses the adoption of digital healthcare solutions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the AI in Pathology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the AI in Pathology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the AI in Pathology Market, highlighting leading vendors and their innovative profiles. These include aetherAI, Aiforia Technologies Oyj, Akoya Biosciences, Inc., Deep Bio, Inc., Evident Corporation, F. Hoffmann-La Roche Ltd., Ibex Medical Analytics Ltd., Indica Labs, Inc., Inspirata, Inc., LUMEA, Inc., MindPeak GmbH, Nucleai Inc., OptraSCAN Inc., Paige.AI, Inc., PathAI, Inc., Proscia Inc., Techcyte, Inc., Tempus Labs, Inc., Tribun Health, Visikol, Inc. by CELLINK, and Visiopharm A/S.

Market Segmentation & Coverage

This research report categorizes the AI in Pathology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Hardware
    • Software
  • Neural Network
    • Convolutional neural networks (CNNs)
    • Generative adversarial networks (GANs)
    • Recurrent neural networks (RNNs)
  • Application
    • Clinical Workflow
    • Disease Diagnosis & Prognosis
    • Drug Discovery
    • Training & Education
  • End-User
    • Academic & Research Institutes
    • Hospitals
    • Pharmaceuticals & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the AI in Pathology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the AI in Pathology Market?

3. What are the technology trends and regulatory frameworks in the AI in Pathology Market?

4. What is the market share of the leading vendors in the AI in Pathology Market?

5. Which modes and strategic moves are suitable for entering the AI in Pathology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. AI in Pathology Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing digitalization of pathology worldwide
      • 5.1.1.2. Growing need for telepathology with the prevalence of chronic disease
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with AI in pathology
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in AI in pathology
      • 5.1.3.2. Rising demand for personalized and customized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with data privacy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Extensive software applications in pathology for seamless workflows and efficient data management
    • 5.2.2. Neural Network: Increasing generative adversarial networks adoption due to diagnostic accuracy and efficiency
    • 5.2.3. Application: Wide utilization of AI in pathology for disease diagnosis to facilitate early detection of diseases
    • 5.2.4. End-User: Expansion of pathology AI in pharmaceuticals & biotechnology companies for discovering potential therapeutics
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. AI in Pathology Market, by Component

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Software

7. AI in Pathology Market, by Neural Network

  • 7.1. Introduction
  • 7.2. Convolutional neural networks (CNNs)
  • 7.3. Generative adversarial networks (GANs)
  • 7.4. Recurrent neural networks (RNNs)

8. AI in Pathology Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Workflow
  • 8.3. Disease Diagnosis & Prognosis
  • 8.4. Drug Discovery
  • 8.5. Training & Education

9. AI in Pathology Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals
  • 9.4. Pharmaceuticals & Biotechnology Companies

10. Americas AI in Pathology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific AI in Pathology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa AI in Pathology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. Microsoft Collab to Build World's Largest Pathology, Oncology Imaging AI
      • 13.3.1.2. Paige and Leica Biosystems Announce Expanded Partnership to Enhance Use of Image Management and Artificial Intelligence Technology in Global Digital Pathology Workflows
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. PathAI Announces PathExplore, an AI-powered Pathology Panel to Unlock Untapped Insights from the Tumor Microenvironment

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. aetherAI
    • 14.1.2. Aiforia Technologies Oyj
    • 14.1.3. Akoya Biosciences, Inc.
    • 14.1.4. Deep Bio, Inc.
    • 14.1.5. Evident Corporation
    • 14.1.6. F. Hoffmann-La Roche Ltd.
    • 14.1.7. Ibex Medical Analytics Ltd.
    • 14.1.8. Indica Labs, Inc.
    • 14.1.9. Inspirata, Inc.
    • 14.1.10. LUMEA, Inc.
    • 14.1.11. MindPeak GmbH
    • 14.1.12. Nucleai Inc.
    • 14.1.13. OptraSCAN Inc.
    • 14.1.14. Paige.AI, Inc.
    • 14.1.15. PathAI, Inc.
    • 14.1.16. Proscia Inc.
    • 14.1.17. Techcyte, Inc.
    • 14.1.18. Tempus Labs, Inc.
    • 14.1.19. Tribun Health
    • 14.1.20. Visikol, Inc. by CELLINK
    • 14.1.21. Visiopharm A/S
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing